Together we will beat cancer

Donate

Combination immunotherapy for advanced bowel cancer approved for NHS in England

People who have previously been treated for a type of bowel cancer that has spread to other parts of their body will now have another treatment option in England.

Read More

Potentially life-extending treatment for lung cancer available in England

A potentially life-extending treatment for some people with non small cell lung cancer (NSCLC) will now be available on the NHS in England.

Read More

Three new cancer drugs approved for NHS in Scotland

The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma.

Read More

Prostate cancer treatment approved in England

Following its approval in Scotland 2 weeks ago, a new treatment will now be available on the NHS in England for some people with prostate cancer.

Read More

Four new cancer drugs approved on NHS in Scotland

The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers.

Read More

Rare bowel cancer treatment combo gets initial no for NHS use in England  

A drug combination for people with a rare type of bowel cancer has received an initial rejection from the National Institute for Health and Care Excellence.

Read More

Non-Hodgkin lymphoma treatment gets the green light for NHS use in England 

The National Institute for Health and Care Excellence has recommended a new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma.

Read More

New treatment for rare blood cancer approved for NHS use in England

The National Institute for Health and Care Excellence (NICE) has approved the drug brentuximab vedotin on the NHS in England.

Read More

Immunotherapy treatment recommended for advanced small cell lung cancer 

A new immunotherapy treatment has been recommended by the National Institute for Health and Care Excellence (NICE) for some adults with small cell lung cancer.

Read More

Non-Hodgkin lymphoma treatment gets an initial ‘no’ for NHS use in England

A new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma has not been recommended for NHS use in England. 

Read More